Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution
| Brand name | BUDESONIDE |
| Generic name | BUDESONIDE |
| Active ingredient(s) | BUDESONIDE |
| Distributed by / for | Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512 |
| NDC | 47335-633-49 |
| Full product label | Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 pouches per carton, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Baska Ujeti Road, Ujeti Halol-289350, Gujarat, India, NDC 47335-633-49. |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide within the United States |
| Quantity | N/A |
| Recall initiated | 2026-05-29 |
| Report date | 2026-06-17 |
| Recall completed | — |
| Recall number | D-0607-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗